Cargando…

Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble Leishmania major Antigens

BACKGROUND: Whole killed Leishmania vaccine reached phase III clinical trials but failed to display significant efficacy in human mainly due to limited Th1 inducer adjuvant. Liposomes consisting of 1, 2-dioleoyl-3trimethylammonium-propane (DOTAP) bearing an inherent adjuvanticity and 1, 2-dioleoyl-L...

Descripción completa

Detalles Bibliográficos
Autores principales:	HOJATIZADE, Mansure, BADIEE, Ali, KHAMESIPOUR, Ali, JAAFARI, Mahmoud Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511587/ https://www.ncbi.nlm.nih.gov/pubmed/31123470

Ejemplares similares

The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2016)

Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c Mice
por: Chavoshian, Omid, et al.
Publicado: (2013)

Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2019)

Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery
por: Sun, Mengwei, et al.
Publicado: (2022)

Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012)

Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice
por: Tada, Rui, et al.
Publicado: (2017)

Sphingomyelin liposome bearing whole Leishmania lysate antigens induce strong Th2 immune response in BALB/c mice
por: Biari, Nazanin, et al.
Publicado: (2021)

Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (ALM) and Quillaja Saponins
por: Tafaghodi, Mohsen, et al.
Publicado: (2016)

Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice
por: Tada, Rui, et al.
Publicado: (2015)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
por: Hejazi, H, et al.
Publicado: (2010)

Efficient siRNA Delivery by the Cationic Liposome DOTAP in Human Hematopoietic Stem Cells Differentiating into Dendritic Cells
por: Martino, Sabata, et al.
Publicado: (2009)

Influence of the Charge Ratio of Guanine-Quadruplex Structure-Based CpG Oligodeoxynucleotides and Cationic DOTAP Liposomes on Cytokine Induction Profiles
por: Le, Nguyen Bui Thao, et al.
Publicado: (2023)

Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin Ghaffari, et al.
Publicado: (2014)

Potential biomarkers of immune protection in human leishmaniasis
por: Rostami, Mahmoud Nateghi, et al.
Publicado: (2021)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica: study protocol for a randomized, controlled trial
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2021)

Improvement of the Solubility Amphotericin B Using Olive Oil Nanoemulsion Coated with Chitosan for More Effective Treatment of Zoonotic Cutaneous Leishmaniasis
por: Taghizadeh, Elnaz, et al.
Publicado: (2021)

Oxidative Stress Can Affect the Gene Silencing Effect of DOTAP Liposome in an In Vitro Translation System
por: Umakoshi, Hiroshi, et al.
Publicado: (2011)

Diccionario ch'ol-español, español-ch'ol
por: Aulie, H. Wilbur
Publicado: (1978)

Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice
por: Gandhapudi, Siva K., et al.
Publicado: (2023)

Immune Responses in Cutaneous Leishmaniasis: In vitro Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed Leishmania major
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2021)

Leishmania mexicana Gp63 cDNA Using Gene Gun Induced Higher Immunity to L. mexicana Infection Compared to Soluble Leishmania Antigen in BALB/C
por: Rezvan, H, et al.
Publicado: (2011)

Vocabulario Chol
Publicado: (1953)

Ch'ol : ityoj ts'ijbuñtyel lakty'añ ch'ol = Norma de escritura de la lengua ch'ol.
Publicado: (2011)

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2018)

The effect of 1,2-dioleoyl-3-trimethylammonium propane (DOTAP) Addition on the physical characteristics of β-ionone liposomes
por: Miatmoko, Andang, et al.
Publicado: (2023)

Gramática ch'ol
por: Warkentin, Viola
Publicado: (1980)

Chol texts on the supernatural /
por: Whittaker, Arabelle
Publicado: (1965)

Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice
por: Calvo, Alba, et al.
Publicado: (2020)

The interaction between BSA and DOTAP at the air-buffer interface
por: Xu, Guoqing, et al.
Publicado: (2018)

Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice
por: Solana, José Carlos, et al.
Publicado: (2020)

Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites
por: Hadighi, Ramtin, et al.
Publicado: (2006)

Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis
por: Viana, Sayonara M., et al.
Publicado: (2018)

Immunization against Leishmania major infection in BALB/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens
por: Salehi-Sangani, Ghodratollah, et al.
Publicado: (2019)

The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946
por: Rahimi, Sara, et al.
Publicado: (2023)

Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023)

Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice
por: Danesh-Bahreini, Mohammad Ali, et al.
Publicado: (2011)

Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice
por: Roychoudhury, Jayeeta, et al.
Publicado: (2011)

Effects of topical gel formulation of Ficus carica latex on cutaneous leishmaniasis induced by Leishmania major in BALB/c mice
por: Pouryousef, Ali, et al.
Publicado: (2021)

Liposome nano‐formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH‐responsive carrier for molecular therapeutic drug (all‐trans retinoic acid) delivery to lung cancer cells
por: Grace, Viswanathan Mariammal Berlin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ocp8a4rot00m5jfc898d2bk7l2